134 related articles for article (PubMed ID: 12194722)
1. The choice of allogeneic or autologous hematopoietic transplantation for NHL.
Hosing C; Champlin RE
Cytotherapy; 2002; 4(3):259-69. PubMed ID: 12194722
[TBL] [Abstract][Full Text] [Related]
2. Autologous and allogeneic transplantation for aggressive NHL.
Smith SM; Grinblatt D; van Besien K
Cytotherapy; 2002; 4(3):223-40. PubMed ID: 12194719
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
Champlin R; van Besien K ; Giralt S; Khouri I
Curr Oncol Rep; 2000 Mar; 2(2):182-91. PubMed ID: 11122842
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL.
Sandlund JT; Bowman L; Heslop HE; Krance R; Mahmoud H; Pui C-; Hale G; Benaim E
Cytotherapy; 2002; 4(3):253-8. PubMed ID: 12194721
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Holmberg LA; Stewart FM
Oncology (Williston Park); 2003 May; 17(5):627-32, 635, 640; discussion 640-2. PubMed ID: 12800792
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center.
Molina A; Popplewell L; Kashyap A; Nademanee A
Clin Transpl; 2000; ():317-42. PubMed ID: 11512326
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
Bhatt VR; Vose JM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
[TBL] [Abstract][Full Text] [Related]
9. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
10. Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.
Satwani P; Jin Z; Martin PL; Bhatia M; Garvin JH; George D; Chaudhury S; Talano J; Morris E; Harrison L; Sosna J; Peterson M; Militano O; Foley S; Kurtzberg J; Cairo MS
Leukemia; 2015 Feb; 29(2):448-55. PubMed ID: 24938649
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
12. Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
Hosing C; Saliba RM; McLaughlin P; Andersson B; Rodriguez MA; Fayad L; Cabanillas F; Champlin RE; Khouri IF
Ann Oncol; 2003 May; 14(5):737-44. PubMed ID: 12702528
[TBL] [Abstract][Full Text] [Related]
13. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
14. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
15. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
[TBL] [Abstract][Full Text] [Related]
16. Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic leukemia.
Khouri IF
Hematology Am Soc Hematol Educ Program; 2006; ():390-7. PubMed ID: 17124088
[TBL] [Abstract][Full Text] [Related]
17. Transplantation for non-Hodgkin lymphoma.
Nademanee A
Expert Rev Hematol; 2009 Aug; 2(4):425-42. PubMed ID: 21082947
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
Maloney D
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S35-S36. PubMed ID: 18724296
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning.
Rezvani AR; Kanate AS; Efron B; Chhabra S; Kohrt HE; Shizuru JA; Laport GG; Miklos DB; Benjamin JE; Johnston LJ; Arai S; Weng WK; Negrin RS; Strober S; Lowsky R
Bone Marrow Transplant; 2015 Oct; 50(10):1286-92. PubMed ID: 26146806
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma.
Ayala E; Figueroa J; Perkins J; Kim J; Yue B; Riches M; Nishihori T; Locke F; Anasetti C; Kharfan-Dabaja MA
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):335-40. PubMed ID: 25659459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
